IBM recently announced its latest blockchain initiative in partnership with KPMG, Merck and Walmart- published at Kenndys Law

Kennedys Law examines recently announced IBMs “latest blockchain initiative in partnership with KPMG, Merck and Walmart. The consortium’s goal is to develop a pharmaceutical blockchain platform that can track drugs as they move through the global supply chain, from manufacturer to end user. ”
… ” Blockchain has been brought to the forefront as stakeholders try to find solutions to comply with the Food and Drug Administration’s (FDA) Drug Supply Chain Security Act 2013 (DSCSA) which impacts the global distribution to pharmacists. The DSCSA requires the pharmaceutical industry to develop an ‘interoperable system’ that can identify, track and trace prescription drugs and vaccines across the supply chain by 2023…”
Read the entire article at : https://www.kennedyslaw.com/thought-leadership/article/blockchain-practical-application-in-the-pharmaceutical-industry